Verona Pharma Plc ADR (NASDAQ: VRNA) Gains 5.59% And Its 6.51% Stock Volatility Is Bewildering

Verona Pharma Plc ADR (NASDAQ:VRNA) does about 1.04M shares in volume on a normal day but saw 1694857 shares change hands in Monday trading. The company now has a market cap of 1.38B USD. Its current market price is $17.01, marking an increase of 5.59% compared to the previous close of $16.11. The 52 week high reached by this stock is $23.07 whilst the lowest price level in 52 weeks is $11.39.

Verona Pharma Plc ADR (VRNA) has a 20-day trading average at $15.03 and the current price is -26.27% off the 52-week high compared with 49.34% distance from its 52-week low. The 50-day simple moving average of the closing price is $14.19 and its 200-day simple moving average is $15.59. If we look at the stock’s price movements over the week, volatility stands at 6.51%, which increases to 7.97% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 64.55 to suggest the stock is neutral.

The consensus objective for the share price is $36.17, suggesting that the stock has a potential upside of 52.97% over the period.

The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 22, 2023 when Jefferies resumed the stock to “Buy” and issued a price target of between $35 and $38. Piper Sandler initiated its price target at $31.

Verona Pharma Plc ADR (VRNA) stock is up 17.63% over the week and 40.12% over the past month. Its price is -14.44% year-to-date and -15.58% over the past year.

To reach the target analysts have set, the stock logically needs to grow 52.97 percent from here.

The company has a return on investment of -23.07% and return on equity of -25.30%. The beta has a value of 0.44. Price to book ratio is 6.12.